September 20, 2001Internal Medicine Journal
Underuse of beta‐blockers following myocardial infarction: a tale of two cities
Key result
Newcastle location is linked to ~70% lower odds of post-MI beta-blocker prescribing versus Perth.
- OR 0.3
- 95% CI 0.3-0.3
- n=6,269
Why the study?
What factors are associated with the underuse of beta-blockers following myocardial infarction?
Population
6,269 patients discharged from hospital after confirmed myocardial infarction from 1985 to 1993.
Comparison
Beta-blocker therapy vs Non-use of beta-blockers
Design
Cohort
Authors
Discussion
Loading...
Member takes
Implication
Geographic disparities drive post-MI beta-blocker underuse; leaves open whether region-specific interventions improve secondary prevention.
Study Design
Type
Observational (n=6,269)
Multicenter
Yes
Structured PICO
What factors are associated with the underuse of beta-blockers following myocardial infarction?
P
Population
6,269 patients discharged from hospital after confirmed myocardial infarction between 1985 and 1993 in Newcastle and Perth.
E
Exposure
Beta-blocker therapy
C
Comparator
Non-use of beta-blockers
O
Outcome
Rates of beta-blocker use before and after hospital discharge and correlates of beta-blocker use
Main Result
Odds Ratio: 0.3 (95% CI 0.3–0.3)
Absolute Event Rate: 45% vs 68%
Significant geographic variation and underuse of beta-blockers in high-risk post-MI patients (e.g., those with diabetes or LV dysfunction) highlight major gaps in secondary prevention prescribing.
Cite This Study
Nicholls et al. (2001) conducted an observational in Myocardial infarction (n=6,269). Geographical centre (Newcastle) vs. Perth was evaluated on Discharge on beta-blockers (OR 0.3, 95% CI 0.3-0.3). Geographical location strongly influenced beta-blocker prescribing after myocardial infarction, with patients in Newcastle less likely to receive them than in Perth (45% vs 68%; OR 0.3, 95% CI 0.3-0.3).